Loading clinical trials...
Loading clinical trials...
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Conditions
Interventions
HuCNS-SC sub-retinal transplantation
Locations
12
United States
Retina Associates Southwest, PC
Tucson, Arizona, United States
Retina Vitreous Associates Medical Group
Beverly Hills, California, United States
Retinal Diagnostic Center
Campbell, California, United States
Northern California Retina Vitreous Associates
Mountain View, California, United States
Retina Research Institute of Texas
Palo Alto, California, United States
Rush University Med Ctr.
Chicago, Illinois, United States
Start Date
June 1, 2015
Primary Completion Date
May 1, 2016
Completion Date
May 1, 2016
Last Updated
June 2, 2016
NCT05913063
NCT06990269
NCT06970665
NCT07160179
NCT06557460
NCT05562947
Lead Sponsor
StemCells, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions